Search

Your search keyword '"Joanne B. Severe"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Joanne B. Severe" Remove constraint Author: "Joanne B. Severe" Topic male Remove constraint Topic: male
36 results on '"Joanne B. Severe"'

Search Results

1. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

2. Comparison of SGA Oral Medications and a Long-Acting Injectable SGA

3. Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials

4. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results

5. Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

6. Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD

7. 3-Year Follow-up of the NIMH MTA Study

8. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder

9. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

10. Duration of Untreated Psychosis in Community Treatment Settings in the United States

11. Emergency/Adjunct Services and Attrition Prevention for Randomized Clinical Trials in Children: The MTA Manual-Based Solution

12. Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA)

13. Medication Prescription Practices for the Treatment of First Episode Schizophrenia-Spectrum Disorders: Data from the National RAISE-ETP Study

14. Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA

15. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders : Baseline results from the RAISE-ETP study

16. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects

17. The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes

18. The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics

19. Reliability of the services for children and adolescents-parent interview

20. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial

21. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures

22. Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods

23. Which treatment for whom for ADHD? Moderators of treatment response in the MTA

24. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD

25. Socioeconomic Status as a Moderator of ADHD Treatment Outcomes

26. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

27. Symptom profiles in children with ADHD: effects of comorbidity and gender

28. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

29. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices

30. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment

31. Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder

32. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate

33. Medication treatment strategies in the MTA study: Relevance to clinicians and researchers

34. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers

35. Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics

36. Prevention of Relapse in Schizophrenia

Catalog

Books, media, physical & digital resources